title: In Reply: Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value.
authors.affiliation: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Whiting
authors.affiliation: Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Duncan
authors.affiliation: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
authors.forename: Rafael J
authors.initials: RJ
authors.lastname: Sierra
authors.affiliation: Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Hugh M
authors.initials: HM
authors.lastname: Smith
mesh_terms: D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001178:Arthroplasty; D019645:Arthroplasty, Replacement, Knee; D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D006454:Hemoglobins; D006801:Humans; D019106:Postoperative Hemorrhage / Q000188:drug therapy; D014148:Tranexamic Acid / Q000627:therapeutic use*
chemical_list: D000933:Antifibrinolytic Agents; D006454:Hemoglobins; D014148:Tranexamic Acid